Kaitlyn Arsenault insider trades
Open-market stock purchases and sales by Kaitlyn Arsenault, Chief Financial Officer at Skye Bioscience, Inc, from SEC Form 4 filings since Aug 25, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 6, 2026 | SKYE Skye Bioscience, Inc | Bought (not open market) | — |
Companies traded
- SKYE Skye Bioscience, Inc: 4 sales, last Feb 6, 2026